152 related articles for article (PubMed ID: 3859940)
21. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
22. [Cyto-destruction of leukemic blasts in vitro using a monoclonal antibody and complement].
Pérez-Oteyza J; Brieva JA; Odriozola J; Bootello A; Navarro JL
Sangre (Barc); 1986; 31(5):587-92. PubMed ID: 2949378
[No Abstract] [Full Text] [Related]
23. Application of monoclonal antibodies to tumor diagnosis and therapy.
Rosen ST; Winter JN; Epstein AL
Ann Clin Lab Sci; 1983; 13(3):173-84. PubMed ID: 6347022
[TBL] [Abstract][Full Text] [Related]
24. Distribution of a new B-cell-associated surface antigen (BL7) detected by a monoclonal antibody in human leukemic disorders.
Al-Katib A; Wang CY; Koziner B
Cancer Res; 1985 Jul; 45(7):3058-63. PubMed ID: 3924396
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibody (WI-2) reactive against human transformed and leukemic cells.
Aota F; Chang D; Hill NO; Khan A
Jpn J Clin Oncol; 1984 Dec; 14(4):575-84. PubMed ID: 6520969
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
27. A new set of monoclonal antibodies against acute lymphoblastic leukemia.
Boucheix C; Perrot JY; Mirshahi M; Giannoni F; Billard M; Bernadou A; Rosenfeld C
Leuk Res; 1985; 9(5):597-604. PubMed ID: 2409408
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies to human tumor antigens.
Steplewski Z
Transplant Proc; 1980 Sep; 12(3):384-7. PubMed ID: 7222217
[No Abstract] [Full Text] [Related]
29. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
Baryshnikov AIu
Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
[TBL] [Abstract][Full Text] [Related]
30. A monoclonal antibody to myelogenous leukemia: isolation and characterization.
Malcolm AJ; Shipman RC; Logan PM; Levy JG
Exp Hematol; 1984 Aug; 12(7):539-47. PubMed ID: 6589167
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies against human malignant melanoma.
Sorg C; Brüggen J; Suter L; Bröcker EB
Bull Cancer; 1983; 70(2):113-7. PubMed ID: 6871486
[TBL] [Abstract][Full Text] [Related]
32. Obtention of rat monoclonal antibodies reactive with human leukaemic lymphoblasts.
Lebacq AM; Bazin H
Bull Cancer; 1983; 70(2):93-5. PubMed ID: 6575843
[TBL] [Abstract][Full Text] [Related]
33. [HLA typing and application of monoclonal antibodies].
Ikeda H; Wakisaka A
Nihon Rinsho; 1983; 41(4):841-5. PubMed ID: 6887551
[No Abstract] [Full Text] [Related]
34. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
Beketić-Oresković L; Sarcević B; Malenica B; Novak D
Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
36. Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia.
Ritz J; Pesando JM; Notis-McConarty J; Clavell LA; Sallan SE; Schlossman SF
Cancer Res; 1981 Nov; 41(11 Pt 2):4771-5. PubMed ID: 6945904
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
38. [Monoclonal antibodies against human differentiated thymocyte antigens].
Baryshnikov AIu
Biull Eksp Biol Med; 1984 Sep; 98(9):324-6. PubMed ID: 6333255
[TBL] [Abstract][Full Text] [Related]
39. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
40. [Clinical use of antineoplastic cell antibody].
Mitomo Y; Mizokami M; Ueda R
Nihon Rinsho; 1981 Aug; 39(8):2832-6. PubMed ID: 7038208
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
